ESTRO Vision 2030.
"Radiation Oncology. Optimal Health for all, together."
If, by 2035, every cancer patient who needs radiotherapy has access to it, almost one million more lives will be saved every year worldwide.
ESTRO has over 7600 members - professionals of radio oncology and beyond, in over 100 countries.
ESTRO 2020 becomes a fully online congress.
Consult our FAQs on the event's pages
Assessment of cancer aggressiveness by functional magnetic resonance imaging (MRI) - Physics Corner
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase III trial - Read It
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase III, non-inferiority trial - Read It
ESTRO 2020 Online Congress: Contouring workshops & Pre-meetings
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase III trial - Read It
ESTRO 2020 Online Congress
Ten-Year Results of FAST: A Randomised Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer - Read It